{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:34:01Z","timestamp":1787009641535,"version":"build-2736575974"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dupuytren\u2019s disease (DD) and Peyronie\u2019s disease (PD) are fibroproliferative disorders that may share common pathophysiological mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To determine the prevalence of PD among male patients diagnosed with DD and to investigate its clinical and laboratory correlates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional observational study was conducted at a tertiary academic center and included 101 male patients diagnosed with DD. All participants underwent structured andrological evaluation and were classified into PD and non-PD groups. Clinical and laboratory parameters\u2014including demographic, metabolic, sexual function, and inflammatory markers\u2014were compared between the groups. Statistical analyses included descriptive statistics, Chi-square or Fisher\u2019s exact tests for categorical variables, and Mann\u2013Whitney U tests for continuous variables. Binary logistic regression was performed to identify independent predictors of concomitant PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>The primary outcome was the prevalence of PD among patients with DD. Secondary outcomes included associations between PD and clinical\/laboratory features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PD was significantly associated with bilateral Dupuytren\u2019s contracture (86.4% vs. 50.6%, P\u2009=\u20090.003), diabetes mellitus (81.8% vs. 44.3%, P\u2009=\u20090.003), lower high-density lipoprotein cholesterol (median 38 vs. 43\u00a0mg\/dL, P\u2009=\u20090.030), higher fasting glucose (median 146 vs. 104\u00a0mg\/dL, P\u2009=\u20090.018), and higher HbA1c (median 7.55% vs. 6.20%, P\u2009=\u20090.005).<\/jats:p>\n                    <jats:p>Erectile function, assessed by the Erection Hardness Score, differed significantly between groups (median 3 in both; interquartile range: 2\u20133 in the PD group vs. 3\u20134 in the non-PD group, P\u2009=\u20090.007) (no significant differences were observed in the 6-item International Index of Erectile Function and the Sexual Health Inventory for Men scores).<\/jats:p>\n                    <jats:p>In multivariate analysis, bilateral DD (OR\u2009=\u200917.80, P\u2009=\u20090.020) and HbA1c (OR\u2009=\u20091.589, P\u2009=\u20090.031) remained independently associated with PD. Other variables did not differ significantly between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Implications<\/jats:title>\n                    <jats:p>Male patients with DD\u2014especially those with bilateral hand involvement or poor glycemic control\u2014may warrant consideration for opportunistic urological evaluation to identify concomitant PD. However, further research is needed to determine the impact of early detection on patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Strengths and Limitations<\/jats:title>\n                    <jats:p>This study is among the few to explore the prevalence and clinical correlates of PD in patients with DD, using a structured urological evaluation and comprehensive laboratory profiling. However, its cross-sectional design limits causal inference, and the single-center setting may affect the generalizability of the findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PD is highly prevalent among patients with DD, especially those with bilateral contracture and poor glycemic control. These findings support a possible systemic fibrotic predisposition and highlight the value of integrated metabolic and sexual health assessment in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/sexmed\/qfaf083","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T11:47:15Z","timestamp":1758628035000},"source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and clinical correlates of Peyronie\u2019s disease in patients with Dupuytren\u2019s disease: a cross-sectional study from a tertiary andrology center"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7891-9450","authenticated-orcid":false,"given":"G\u00f6khan","family":"\u00c7eker","sequence":"first","affiliation":[{"name":"Department of Urology, Basaksehir Cam and Sakura City Hospital , Istanbul, 34480 ,","place":["Turkey"]},{"name":"Department of Histology and Embryology, Hamidiye Institute of Health Sciences, University of Health Sciences , Istanbul , 34668,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9639-7577","authenticated-orcid":false,"given":"Ertu\u011frul","family":"Ar\u0131k\u0131z","sequence":"additional","affiliation":[{"name":"Department of Urology, Basaksehir Cam and Sakura City Hospital , Istanbul, 34480 ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-8288","authenticated-orcid":false,"given":"Akif","family":"Erbin","sequence":"additional","affiliation":[{"name":"Department of Urology, Basaksehir Cam and Sakura City Hospital , Istanbul, 34480 ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-0213","authenticated-orcid":false,"given":"Hakan","family":"An\u0131l","sequence":"additional","affiliation":[{"name":"Department of Urology, Adana City Training and Research Hospital , Adana, 01230 ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6481-7907","authenticated-orcid":false,"given":"Halil L\u00fctfi","family":"Canat","sequence":"additional","affiliation":[{"name":"Department of Urology, Basaksehir Cam and Sakura City Hospital , Istanbul, 34480 ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"6","key":"2025111708574629300_ref1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1517\/14656566.2011.544252","article-title":"Current status and new developments in Peyronie\u2019s disease: medical, minimally invasive and surgical treatment options","volume":"12","author":"Gur","year":"2011","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"2025111708574629300_ref2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0022-5347(01)68236-3","article-title":"An animal model of Peyronie\u2019s-like condition associated with an increase of transforming growth factor Beta mRNA and protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J Urol"},{"issue":"3","key":"2025111708574629300_ref3","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/J.1464-410X.2006.05969.X","article-title":"Risk factors for Peyronie\u2019s disease: a case-control study","volume":"97","author":"Bjekic","year":"2006","journal-title":"BJU Int"},{"issue":"2","key":"2025111708574629300_ref4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/J.UROLOGY.2004.04.006","article-title":"Comparison of gene expression profiles between Peyronie\u2019s disease and Dupuytren\u2019s contracture","volume":"64","author":"Qian","year":"2004","journal-title":"Urology."},{"issue":"7","key":"2025111708574629300_ref5","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1111\/J.1743-6109.2010.01850.X","article-title":"The Management of Peyronie\u2019s disease: evidence-based 2010 guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J Sex Med"},{"issue":"4","key":"2025111708574629300_ref6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/IJIR.2011.18","article-title":"The association between Peyronie\u2019s and Dupuytren\u2019s disease","volume":"23","author":"Nugteren","year":"2011","journal-title":"Int J Impot Res"},{"issue":"4","key":"2025111708574629300_ref7","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1097\/PRS.0000000000006642","article-title":"Prevalence of Peyronie and Ledderhose diseases in a series of 730 patients with Dupuytren disease","volume":"145","author":"Mohede","year":"2020","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"2025111708574629300_ref8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/J.EURURO.2025.04.010","article-title":"European Association of Urology guidelines on male sexual and reproductive health: 2025 update on male hypogonadism, erectile dysfunction, premature ejaculation, and Peyronie\u2019s disease","volume":"88","author":"Salonia","year":"2025","journal-title":"Eur Urol"},{"issue":"2","key":"2025111708574629300_ref9","doi-asserted-by":"publisher","DOI":"10.1002\/EDM2.195","article-title":"Fibroproliferative disorders and diabetes: understanding the pathophysiologic relationship between Peyronie\u2019s disease, Dupuytren disease and diabetes","volume":"4","author":"Gelbard","year":"2021","journal-title":"Endocrinol Diabetes Metab"},{"issue":"3","key":"2025111708574629300_ref10","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/J.ESXM.2017.06.001","article-title":"Prevalence of Peyronie\u2019s disease-like symptoms in men presenting with Dupuytren contractures","volume":"5","author":"Shindel","year":"2017","journal-title":"Sex Med"},{"issue":"7","key":"2025111708574629300_ref11","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1046\/J.1464-4096.2001.02436.X","article-title":"The prevalence of Peyronie\u2019s disease: results of a large survey","volume":"88","author":"Schwarzer","year":"2001","journal-title":"BJU Int"},{"issue":"4","key":"2025111708574629300_ref12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/J.ESXM.2020.09.002","article-title":"A population-based study of Peyronie\u2019s disease in Turkey: prevalence and related comorbidities","volume":"8","author":"Kadioglu","year":"2020","journal-title":"Sex Med"},{"issue":"2","key":"2025111708574629300_ref13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/J.JHSA.2005.09.018","article-title":"The heritability of Dupuytren\u2019s disease: familial aggregation and its clinical significance","volume":"31","author":"Hindocha","year":"2006","journal-title":"J Hand Surg Am"},{"issue":"2","key":"2025111708574629300_ref14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/1753193414535720","article-title":"Genetic and environmental influences in Dupuytren\u2019s disease: a study of 30,330 Danish twin pairs","volume":"40","author":"Larsen","year":"2015","journal-title":"J Hand Surg Eur"},{"issue":"4","key":"2025111708574629300_ref15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1177\/1753193412453359","article-title":"Sibling recurrence risk in Dupuytren\u2019s disease","volume":"38","author":"Capstick","year":"2013","journal-title":"J Hand Surg Eur"},{"issue":"7","key":"2025111708574629300_ref16","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/ANDR.13223","article-title":"Significant familial clustering of Peyronie\u2019s disease in close and distant relatives","volume":"10","author":"Allen-Brady","year":"2022","journal-title":"Andrology."},{"issue":"3","key":"2025111708574629300_ref17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2147\/VHRM.S1991","article-title":"Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers","volume":"4","author":"Ban","year":"2008","journal-title":"Vasc Health Risk Manag"},{"issue":"3","key":"2025111708574629300_ref18","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1097\/01.JU.0000170231.51306.32","article-title":"Peyronie\u2019s disease in diabetic patients being screened for erectile dysfunction","volume":"174","author":"El-Sakka","year":"2005","journal-title":"J Urol"},{"issue":"1","key":"2025111708574629300_ref19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4081\/aiua.2015.1.20","article-title":"Smoking, diabetes, blood hypertension: possible etiologic role for Peyronie\u2019s disease? Analysis in 279 patients with a control group in Sicily","volume":"87","author":"Pavone","year":"2015","journal-title":"Archivio Italiano di Urologia e Andrologia"},{"issue":"6","key":"2025111708574629300_ref20","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/DIABETES.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes."},{"issue":"3","key":"2025111708574629300_ref21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4103\/AJA.AJA_74_20","article-title":"Role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in Peyronie\u2019s disease: a new diagnostic approach to predict the stage of the disease?","volume":"23","author":"Rojo","year":"2021","journal-title":"Asian J Androl"},{"issue":"2","key":"2025111708574629300_ref22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/ANDR.12702","article-title":"The role of inflammatory parameters (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-eosinophil ratio) in patients with Peyronie\u2019s disease","volume":"8","author":"\u00d6zbir","year":"2020","journal-title":"Andrology."},{"issue":"6","key":"2025111708574629300_ref23","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1111\/J.1743-6109.2007.00600.X","article-title":"Validation of the erection hardness score","volume":"4","author":"Mulhall","year":"2007","journal-title":"J Sex Med"},{"issue":"Supplement_6","key":"2025111708574629300_ref24","doi-asserted-by":"publisher","DOI":"10.1093\/JSXMED\/QDAE161.241","article-title":"(316) assessment of erectile dysfunction and Peyronie disease: a study using the erection hardness score and IIEF questionnaire","volume":"21","author":"Rocha","year":"2024","journal-title":"J Sex Med"},{"key":"2025111708574629300_ref25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.knee.2021.02.009","article-title":"Patients with Dupuytren\u2019s contracture, Ledderhose disease, and Peyronie\u2019s disease are at higher risk of arthrofibrosis following total knee arthroplasty","volume":"29","author":"Wang","year":"2021","journal-title":"Knee."},{"issue":"3","key":"2025111708574629300_ref26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/S10792-018-0837-Y","article-title":"Peyronie\u2019s disease and Dupuytren\u2019s contracture secondary to topical timolol","volume":"39","author":"Oliphant","year":"2019","journal-title":"Int Ophthalmol"},{"issue":"8","key":"2025111708574629300_ref27","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/SJ.EYE.6702088","article-title":"Peyronie\u2019s disease following long-term use of topical timolol","volume":"20","author":"Ross","year":"2006","journal-title":"Eye."},{"issue":"5","key":"2025111708574629300_ref28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/NRL.0000000000000240","article-title":"Dupuytren, Ledderhose, and Peyronie diseases after Primidone use for essential tremor","volume":"24","author":"Vasconcellos","year":"2019","journal-title":"Neurologist."},{"issue":"2","key":"2025111708574629300_ref29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0049-0172(73)90009-7","article-title":"Dupuytren\u2019s contracture: a review","volume":"3","author":"Viljanto","year":"1973","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"2025111708574629300_ref30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/0002-9394(73)90098-6","article-title":"Cataracts, Dupuytren\u2019s contracture, and alcohol addiction","volume":"76","author":"Sabiston","year":"1973","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2025111708574629300_ref31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.26402\/JPP.2022.1.05","article-title":"Are insulin resistance and non-alcoholic fatty liver disease associated with Peyronie\u2019s disease?","volume":"73","author":"Crocetto","year":"2022","journal-title":"A pilot study J Physiol Pharmacol"},{"issue":"2","key":"2025111708574629300_ref32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/J.AJUR.2015.04.019","article-title":"All about Peyronie\u2019s disease","volume":"2","author":"Hussein","year":"2015","journal-title":"Asian J Urol"},{"issue":"3","key":"2025111708574629300_ref33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.21037\/TAU.2016.05.14","article-title":"Psychological aspects of Peyronie\u2019s disease","volume":"5","author":"Terrier","year":"2016","journal-title":"Transl Androl Urol"}],"container-title":["Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/13\/5\/qfaf083\/64702275\/qfaf083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/13\/5\/qfaf083\/64702275\/qfaf083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T13:57:53Z","timestamp":1763387873000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smoa\/article\/doi\/10.1093\/sexmed\/qfaf083\/8285950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9,29]]}},"URL":"https:\/\/doi.org\/10.1093\/sexmed\/qfaf083","relation":{},"ISSN":["2050-1161"],"issn-type":[{"value":"2050-1161","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,29]]},"article-number":"qfaf083"}}